Mike Botta
Contributing Editor

As a Contributing Editor for Advantage Business Media's manufacturing group, Mike Botta contributes across all of the manufacturing brands, creating content and spearheading a variety of projects. Mike has held senior publishing positions at the Fairchild Publications and Chilton Publishing units of Capital Cities/ABC, Reed Business Information, Advantage Business Media (2006-2007), and Thomas Publishing. He served as Editor-in-Chief of the American Metal Market daily business newspaper for several years, eventually moving up to the position of Publisher. He joined Reed in Rockaway, NJ in 2003 as Editorial Director of the manufacturing publications and was later named Publishing Director of the manufacturing group. When Advantage acquired the Rockaway properties in 2006, Mike was named Director of Content. Most recently he served as Editorial Director of TCC Media’s Industrial Equipment News and handled a variety of special projects for other publications, including production of Show Dailies and in-depth interviews with business leaders. Mike and his family relocated from Northern New Jersey to the suburbs of Phoenix, AZ in 2009.

Express Scripts has decided not to include Ajovy in its 2019 coverage, dealing a blow to the Teva drug's prospects, according to GlobalData.
Contributing Editor
|
10.18.2018
7:00am
Catalent has a multi-year collaboration with Verastem Oncology, providing clinical development, analytical support, and manufacturing services.
Contributing Editor
|
10.17.2018
1:15pm
The U.S. Food and Drug Administration issued another series of updates on drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
10.15.2018
7:00am
The expansion is based on an agreement with a major biopharmaceutical partner that ensures ADC payload supply continuity at reduced cost.
Contributing Editor
|
10.8.2018
1:05pm
The U.S. Food and Drug Administration issued another series of updates on drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
10.3.2018
7:00am
Advertisement
The U.S. Food and Drug Administration issued another series of updates on drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
9.25.2018
7:00am
The U.S. Food and Drug Administration has issued a series of updates on drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
9.17.2018
6:00am
The FDA, in particular, dictates approaches to industry without asking what the commercial justifications are to support them, expert claims.
Contributing Editor
|
8.27.2018
6:00am
Under the leadership of Dr. Chris Chen, WuXi has assembled one of the largest biologics development teams in the world.
Contributing Editor
|
8.24.2018
5:15am
The U.S. Food and Drug Administration has issued a variety of updates on drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
8.22.2018
8:00am
The arrangement aims to reduce costs and provide senior citizens with increased access to over-the counter medicines and services.
Contributing Editor
|
8.20.2018
2:05pm
Finished dosage formulations in the region have been expanding quickly, driven by government reforms to further increase local manufacturing.
Contributing Editor
|
8.17.2018
6:15am
Hailie solution gives patients access through a smartphone app and sensor that attaches to prescription inhaler medication.
Contributing Editor
|
8.14.2018
6:05am
Advertisement
The U.S. Food and Drug Administration has issued a variety of updates on drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
8.10.2018
8:00am
In pharma, deviation from Current Good Manufacturing Practices was the top cause for recalled units and in Medical Devices, sterility was the top cause.
Contributing Editor
|
8.8.2018
9:00am
The U.S. Food and Drug Administration has issued a variety of updates on drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
8.3.2018
9:20am
Sales were down 5.7 percent in the quarter and 7.2 percent in the first half. Exchange rate movements had a negative effect. Growth among diversified...
Contributing Editor
|
7.31.2018
10:59am
The biomarker, which can help target critical early stages of the disease, involves the intravenous injection of a small amount of a radioactive tracer before...
Contributing Editor
|
7.27.2018
8:00am
While releasing its 2Q earnings report Wednesday, GlaxoSmithKline reported that it also agreed to invest $300 million in personal genetic testing service...
Contributing Editor
|
7.25.2018
12:16pm
CRO ObvioHealth has launched ClaimIt, a mobile application for site-less clinical studies that lets participants take part in healthcare research from their...
Contributing Editor
|
7.24.2018
3:05pm
The U.S. Food and Drug Administration has issued updates on several drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
7.24.2018
7:00am
Advertisement
Indivior has been granted a preliminary injunction preventing Dr. Reddy's from selling in the U.S. market a generic version of Indivior's Suboxone...
Contributing Editor
|
7.17.2018
8:14am
Exosomics Siena S.p.A., a Lonza-backed diagnostics company, has launched its first proprietary liquid biopsy technologies for the selective isolation of tumor-...
Contributing Editor
|
7.16.2018
9:00am
The Phase 3 trial of Imbruvica did not meet the primary endpoint of event-free survival in patients with a subtype of diffuse large B-cell lymphoma (DLBCL), an...
Contributing Editor
|
7.13.2018
7:06am
The U.S. Federal Trade Commission's unconditional clearance is a significant step in Takeda's acquisition of Shire plc., which was announced in early...
Contributing Editor
|
7.10.2018
1:05pm
Grafalon is indicated in solid organ transplantation for the prevention and treatment of acute rejection, graft-vs-host disease in stem cell transplants, and...
Contributing Editor
|
7.6.2018
6:00am
A cryptographic ‘fingerprint’ provides tamperproof logs for equipment audits.
Contributing Editor
|
7.1.2018
8:05am
Private equity firm Advent International will acquire Zentiva, Sanofi's European generics business. Transfer of the Zentiva business is anticipated during...
Contributing Editor
|
6.29.2018
2:30pm
The list of off-patent drugs that have no approved generics is designed to encourage submission of abbreviated applications and to increase competition in the...
Contributing Editor
|
6.29.2018
10:13am
Ezutromid failed to meet primary or secondary endpoints after 48 weeks of treatment. Summit now plans to focus on advancing its pipeline of new mechanism...
Contributing Editor
|
6.28.2018
9:39am
The FDA has issued updates on several drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
6.27.2018
8:00am
GE announced Tuesday that it intends to spin off its healthcare business, just days after the company was bounced from the Dow Jones Industrial average.
Contributing Editor
|
6.26.2018
2:44pm
Blink Health, an e-commerce service that uses technology to bypass powerful intermediaries, negotiates drug prices directly with prescription medication...
Contributing Editor
|
6.19.2018
6:30am
The U.S. District Court for the District of New Jersey has granted Indivior a temporary restraining order that compels Dr. Reddy's to immediately cease...
Contributing Editor
|
6.18.2018
9:53am
The annual INTERPHEX Exhibitor Awards program, which is sponsored by Pharmaceutical Processing, recognizes companies that showcase creative technologies and/or...
Contributing Editor
|
6.15.2018
12:46pm
The FDA has issued updates on several drugs that are currently in shortage or have been discontinued.
Contributing Editor
|
6.15.2018
9:22am
Marking its 30th anniversary year, MG America is showcasing its latest equipment options at INTERPHEX and showing how it stays ahead of the ever-evolving...
Contributing Editor
|
6.13.2018
4:30pm
A study found that the compactibility and the physical stability of the tablets were preserved, delivering the high porosity required to absorb the liquid...
Contributing Editor
|
6.12.2018
5:05am
The investment is the first phase of Wasdell Group’s laboratory expansion strategy. The second phase will include the opening of a new lab in Ireland to '...
Contributing Editor
|
6.11.2018
6:15am